These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22626552)

  • 1. Synthesis and SAR of 4-aminocyclopentapyrrolidines as N-type Ca²⁺ channel blockers with analgesic activity.
    Beebe X; Darczak D; Henry RF; Vortherms T; Janis R; Namovic M; Donnelly-Roberts D; Kage KL; Surowy C; Milicic I; Niforatos W; Swensen A; Marsh KC; Wetter JM; Franklin P; Baker S; Zhong C; Simler G; Gomez E; Boyce-Rustay JM; Zhu CZ; Stewart AO; Jarvis MF; Scott VE
    Bioorg Med Chem; 2012 Jul; 20(13):4128-39. PubMed ID: 22626552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and SAR of 4-aminocyclopentapyrrolidines as orally active N-type calcium channel inhibitors for inflammatory and neuropathic pain.
    Beebe X; Yeung CM; Darczak D; Shekhar S; Vortherms TA; Miller L; Milicic I; Swensen AM; Zhu CZ; Banfor P; Wetter JM; Marsh KC; Jarvis MF; Scott VE; Schrimpf MR; Lee CH
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4857-61. PubMed ID: 23876987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scaffold-based design and synthesis of potent N-type calcium channel blockers.
    Zamponi GW; Feng ZP; Zhang L; Pajouhesh H; Ding Y; Belardetti F; Pajouhesh H; Dolphin D; Mitscher LA; Snutch TP
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6467-72. PubMed ID: 19815411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and evaluation of selective N-type calcium channel blockers: 6-unsubstituted-1,4-dihydropyridine-5-carboxylic acid derivatives.
    Yamamoto T; Niwa S; Tokumasu M; Onishi T; Ohno S; Hagihara M; Koganei H; Fujita S; Takeda T; Saitou Y; Iwayama S; Takahara A; Iwata S; Shoji M
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3639-42. PubMed ID: 22560585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity study and analgesic efficacy of amino acid derivatives as N-type calcium channel blockers.
    Seko T; Kato M; Kohno H; Ono S; Hashimura K; Takimizu H; Nakai K; Maegawa H; Katsube N; Toda M
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2067-70. PubMed ID: 11514140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and SAR of novel 2-arylthiazolidinones as selective analgesic N-type calcium channel blockers.
    Knutsen LJ; Hobbs CJ; Earnshaw CG; Fiumana A; Gilbert J; Mellor SL; Radford F; Smith NJ; Birch PJ; Russell Burley J; Ward SD; James IF
    Bioorg Med Chem Lett; 2007 Feb; 17(3):662-7. PubMed ID: 17134896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of diphenylpiperazine N-type calcium channel inhibitors.
    Pajouhesh H; Feng ZP; Ding Y; Zhang L; Pajouhesh H; Morrison JL; Belardetti F; Tringham E; Simonson E; Vanderah TW; Porreca F; Zamponi GW; Mitscher LA; Snutch TP
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1378-83. PubMed ID: 20117000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker.
    Abbadie C; McManus OB; Sun SY; Bugianesi RM; Dai G; Haedo RJ; Herrington JB; Kaczorowski GJ; Smith MM; Swensen AM; Warren VA; Williams B; Arneric SP; Eduljee C; Snutch TP; Tringham EW; Jochnowitz N; Liang A; Euan MacIntyre D; McGowan E; Mistry S; White VV; Hoyt SB; London C; Lyons KA; Bunting PB; Volksdorf S; Duffy JL
    J Pharmacol Exp Ther; 2010 Aug; 334(2):545-55. PubMed ID: 20439438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5beta-reduced neuroactive steroids are novel voltage-dependent blockers of T-type Ca2+ channels in rat sensory neurons in vitro and potent peripheral analgesics in vivo.
    Todorovic SM; Pathirathna S; Brimelow BC; Jagodic MM; Ko SH; Jiang X; Nilsson KR; Zorumski CF; Covey DF; Jevtovic-Todorovic V
    Mol Pharmacol; 2004 Nov; 66(5):1223-35. PubMed ID: 15280444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and preliminary pharmacological evaluation of 4-aminopiperidine derivatives as N-type calcium channel blockers active on pain and neuropathic pain.
    Teodori E; Baldi E; Dei S; Gualtieri F; Romanelli MN; Scapecchi S; Bellucci C; Ghelardini C; Matucci R
    J Med Chem; 2004 Nov; 47(24):6070-81. PubMed ID: 15537361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of trimethoxybenzyl piperazine N-type calcium channel inhibitors.
    Pajouhesh H; Feng ZP; Zhang L; Pajouhesh H; Jiang X; Hendricson A; Dong H; Tringham E; Ding Y; Vanderah TW; Porreca F; Belardetti F; Zamponi GW; Mitscher LA; Snutch TP
    Bioorg Med Chem Lett; 2012 Jun; 22(12):4153-8. PubMed ID: 22579422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship study of 1,4-dihydropyridine derivatives blocking N-type calcium channels.
    Yamamoto T; Niwa S; Ohno S; Onishi T; Matsueda H; Koganei H; Uneyama H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Shoji M
    Bioorg Med Chem Lett; 2006 Feb; 16(4):798-802. PubMed ID: 16309909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery, structure-activity relationship study, and oral analgesic efficacy of cyproheptadine derivatives possessing N-type calcium channel inhibitory activity.
    Yamamoto T; Niwa S; Iwayama S; Koganei H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Yamamoto H; Shoji M
    Bioorg Med Chem; 2006 Aug; 14(15):5333-9. PubMed ID: 16616501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and SAR of a novel series of 2,4,5,6-tetrahydrocyclopenta[c]pyrazoles as N-type calcium channel inhibitors.
    Winters MP; Subasinghe N; Wall M; Beck E; Brandt MR; Finley MF; Liu Y; Lubin ML; Neeper MP; Qin N; Flores CM; Sui Z
    Bioorg Med Chem Lett; 2014 May; 24(9):2057-61. PubMed ID: 24726803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal N-type calcium channel blockers: a series of 4-piperidinylaniline analogs with analgesic activity.
    Hu LY; Ryder TR; Rafferty MF; Siebers KM; Malone T; Chatterjee A; Feng MR; Lotarski SM; Rock DM; Stoehr SJ; Taylor CP; Weber ML; Miljanich GP; Millerman E; Szoke BG
    Drug Des Discov; 2000; 17(1):85-93. PubMed ID: 10928451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of novel T-type calcium channel blockers.
    Choi JY; Seo HN; Lee MJ; Park SJ; Park SJ; Jeon JY; Kang JH; Pae AN; Rhim H; Lee JY
    Bioorg Med Chem Lett; 2007 Jan; 17(2):471-5. PubMed ID: 17064894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic (omega)-conotoxins CVIE and CVIF selectively and voltage-dependently block recombinant and native N-type calcium channels.
    Berecki G; Motin L; Haythornthwaite A; Vink S; Bansal P; Drinkwater R; Wang CI; Moretta M; Lewis RJ; Alewood PF; Christie MJ; Adams DJ
    Mol Pharmacol; 2010 Feb; 77(2):139-48. PubMed ID: 19892914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A-1048400 is a novel, orally active, state-dependent neuronal calcium channel blocker that produces dose-dependent antinociception without altering hemodynamic function in rats.
    Scott VE; Vortherms TA; Niforatos W; Swensen AM; Neelands T; Milicic I; Banfor PN; King A; Zhong C; Simler G; Zhan C; Bratcher N; Boyce-Rustay JM; Zhu CZ; Bhatia P; Doherty G; Mack H; Stewart AO; Jarvis MF
    Biochem Pharmacol; 2012 Feb; 83(3):406-18. PubMed ID: 22153861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potent and selective indole N-type calcium channel (Ca(v)2.2) blocker for the treatment of pain.
    Tyagarajan S; Chakravarty PK; Park M; Zhou B; Herrington JB; Ratliff K; Bugianesi RM; Williams B; Haedo RJ; Swensen AM; Warren VA; Smith M; Garcia M; Kaczorowski GJ; McManus OB; Lyons KA; Li X; Madeira M; Karanam B; Green M; Forrest MJ; Abbadie C; McGowan E; Mistry S; Jochnowitz N; Duffy JL
    Bioorg Med Chem Lett; 2011 Jan; 21(2):869-73. PubMed ID: 21195616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure-activity relationship study on 2-, 5-, and 6-position of the water soluble 1,4-dihydropyridine derivatives blocking N-type calcium channels.
    Yamamoto T; Niwa S; Ohno S; Tokumasu M; Masuzawa Y; Nakanishi C; Nakajo A; Onishi T; Koganei H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Shoji M
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4813-6. PubMed ID: 18684623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.